Fortis Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,966	Closed	-$135K	–	253
2020 Q1	$135K	Buy	2,966 +117	+4%	+$5.33K	0.09%	120
2019 Q4	$185K	Hold	2,849	–	–	0.11%	133
2019 Q3	$177K	Buy	+2,849	New	+$177K	0.08%	139